“The Reply to the Letter to the Editor Regarding: ‘The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study’”, Вопр. онкол., vol. 72, no. 1, p. OF-2568, Mar. 2026, doi: 10.37469/0507-3758-2026-72-1-OF-2568.